OTC Drugs: Monographs and Administrative Orders

A nonprescription product can require an approved drug application or fall within the OTC monograph framework. The monograph route is conditional: ingredients, uses and other characteristics must fit the applicable legal conditions. Products combining cosmetic presentation with drug claims, including some sunscreens and acne products, need an intended-use analysis before selecting a pathway. FDA process explanation.

An OTC monograph addresses active ingredients, indications, dosage, route, labeling and relevant testing. Comparing only the ingredient name is insufficient. Concentration, combination, dosage form and instructions can change the result. The product assessment should identify the governing order and the individual conditions relied upon for the marketed formulation. FDA regulatory questions.

FDA’s order process distinguishes proposed, final and interim final actions. Proposed orders ordinarily provide an opportunity for public comment before final action. An expedited interim final order can take effect before comment in the statutory circumstances. The status and effective provisions of the actual order matter more than the date of a press announcement. Administrative order process.

Industry can submit an OTC monograph order request, or OMOR, asking FDA to add, remove or change conditions. Acceptance for filing and scientific review are separate steps. A filed request does not authorize marketing under the requested new conditions. FDA also initiates orders and provides mechanisms for dispute resolution, hearings and judicial review. FDA process.

Meeting a monograph does not remove drug CGMP, applicable establishment registration and listing, labeling or other statutory duties. A monograph product is not individually approved through an NDA merely because it meets category conditions. Claims made on packaging, websites and advertising must remain consistent with the product’s lawful regulatory position. FDA OTC questions.

Locate the therapeutic category through FDA’s current monograph resources, record the order status and compare the complete product. The historical rulemaking table expressly describes the pre-CARES Act system. It can explain how an order originated but should not be used alone to establish present marketing conditions or the outcome of later changes. Historical table limitation.